results found
This brief is the result of a collaboration between the Kaiser Family Foundation and the United States Bureau of Economic Analysis. Cynthia Cox is with the Kaiser Family Foundation; Abe Dunn, Lindsey Rittmueller, and Bryn Whitmire are with the Bureau …
Compared to similar countries, the United States has higher rates of mortality for most of the leading causes of death, and generally performs worse on a variety of quality indicators. Diabetes and endocrine diseases are no exception. There has been …
The cost of prescription drugs has received a good deal of attention recently, driven in part by a spike is spending in 2014 and 2015. After several years of fairly low growth, per capita prescription drugs costs are estimated to …
Health spending in the U.S. has grown at historically low levels since 2008, likely due to a combination of the economic downturn and slow recovery, as well as structural changes to the health system, such as higher deductibles in private …
Medical spending among people with private coverage may continue to grow at relatively slow rates in 2016, according to the latest Medical Cost Trend: Behind the Numbers report from PwC’s Health Research Institute.
Each year, PwC reports projected medical cost …
A new analysis of trends in utilization of high-cost medication indicates that among patients spending the most on prescription drugs, most are using specialty drugs. Express Scripts’s new findings follow its March 2015 report of a 13.1% jump in prescription …
Although pharmaceutical spending growth has shown signs of picking back up in 2014, it had slowed considerably during the post-recession period (2009-2013) and was one of the primary contributors to the recent health spending slowdown, according to a recent Health …
The largest pharmacy benefits manager in the U.S. recently released its annual 2014 Drug Trend Report, indicating the biggest jump in prescription drug spending since 2003.
According to Express Scripts, prescription drug spending jumped 13.1% from 2013 to 2014. The …
While pharmaceutical spending growth remains historically low in the United States, a recent IMS Health study finds there was a 3.2% increase in spending on medicines in 2013, a bounce back from the 1.0% decline the previous year. On a …
In its June 2014 issue, “Economics of Health Care: Costs, Savings & Value,” the policy journal Health Affairs examines the potential to rein in spending while simultaneously ensuring access and quality, with a particular focus on Medicare and Medicaid.
Researchers …